Revised SPC: Kanuma (sebelipase alfa) 2mg/ml concentrate solution

SPC now states no dosing adjustment required in patients with hepatic impairment. However, no alternative dose regimens can be recommended for patients > 65 years or overweight, as safety and efficacy in these groups has not been evaluated.

Source:

electronic Medicines compendium